دورية أكاديمية

Sofosbuvir/ledipasvir in combination or nitazoxanide alone are safe and efficient treatments for COVID-19 infection: A randomized controlled trial for repurposing antivirals

التفاصيل البيبلوغرافية
العنوان: Sofosbuvir/ledipasvir in combination or nitazoxanide alone are safe and efficient treatments for COVID-19 infection: A randomized controlled trial for repurposing antivirals
المؤلفون: Medhat, Mohammed A., El-Kassas, Mohamed, Karam-Allah, Haidi, Al Shafie, Ahmed, Abd-Elsalam, Sherief, Moustafa, Ehab, Hassany, Sahar M., Salama, Marwa, Abd Elghafar, Mohamed S., Sayed, Hamdy, Badr, Mohamed, Kamal, Dalia T., Shamseldeen, Ahmed, Ossimi, Ashima'a, Moaz, Inas, Esmael, Hossam El-deen, Ezz Eldin, Azza M., Ezzat, Sameera, Abdelghaffar, Hossam, Abdelghaffar, Khaled
المصدر: In Arab Journal of Gastroenterology August 2022 23(3):165-171
قاعدة البيانات: ScienceDirect
الوصف
تدمد:16871979
DOI:10.1016/j.ajg.2022.04.005